| |
|
|
|
|
|
|
|||
|
Blood, 5 February 2009, Vol. 113, No. 6, pp. 1207-1208.
Integrating integrins into HIV pathogenesisNATIONAL INSTITUTES OF HEALTH
In this issue of Blood, Ballana and colleagues show that integrins that mediate macrophage adhesion are important for HIV replication and inhibition of these integrins suppresses HIV replication at the transcriptional level.
It is not surprising that viruses exploit integrins for their own benefit. In recent years, integrins have emerged as attachment or entry receptors for a large number of viruses, including herpes-, rota-, adeno-, and flavi-viruses.1 Obviously, HIV-1 did not lose the opportunity to use integrins as well. Recently, it was reported that the HIV-1 envelope binds and signals through
Here, Ballana et al present evidence that
What contribution do these results offer to the understanding of basic mechanisms of HIV infection and to the development of new anti-HIV therapies? Engagement of integrins with the ECM in the course of differentiation of circulating monocytes into tissue macrophages may enhance viral replication and thus facilitate HIV tissue dissemination. Inhibition of V integrins suppresses HIV replication only partially, and, in spite of this inhibition, cells still remain partially attached. It is possible that molecules (other than the V integrins targeted in this work) that are involved in cell adhesion can play a role in modulating HIV-1 replication by affecting macrophage attachment. In detached cells, other elements of cell machinery besides blockage of integrin-signaling pathways may become incompatible with HIV replication (eg, inappropriate actin polymerization, intracellular pH, calcium levels). Unfortunately, the development of new anti-HIV therapies based on these results is not in sight. First, suppression of integrin expression inhibits HIV replication only by approximately 50%, too little for an efficient therapy. Second, the consequences of severing the adhesion of macrophages and probably other cells to the ECM would be too drastic for this process to be used as a therapeutic intervention. However, the history of science shows that it is often difficult to foresee practical applications of basic scientific discoveries. In this case, full understanding of the complicated and possibly redundant system of integrins may permit targeting of only those that are essential for HIV infection. This work by Ballana et al is a step toward understanding whether this will be possible.
Footnotes
Conflict-of-interest disclosure: The author declares no competing financial interests.
REFERENCES
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||